November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...
Clinical Trials
Clinical trials and studies about imaging technology can be found on this channel.
October 31, 2022 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/University of Cincinnati ...
October 27, 2022 — Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding ...
October 27, 2022 — Researchers at CU Boulder have, for the first time, used X-ray computed tomography (also known as a ...
October 26, 2022 — The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2022 Gold Medal ...
October 26, 2022 — VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has partnered with Wellspring ...
October 24, 2022 — In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings ...
October 23, 2022 — Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and ...
October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five ...
October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with ...
October 4, 2022 — For Black women, breast cancer is the most commonly diagnosed cancer and as of 2019 has surpassed lung ...
September 20, 2022 — Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast ...
September 15, 2022 — University of Minnesota Twin Cities scientists and engineers have found a way to improve the ...
September 15, 2022 — The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering ...
September 2, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, today ...
August 17, 2022 — In a study published today in the Journal of General Internal Medicine, researchers at the Icahn ...
August 16, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...
August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...
August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...
August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...
November 02, 2022 